BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 97766)

  • 1. [Prenatal diagnosis of hemolytic disease of newborns by means of immunofluorescence studies of maternal antibodies on amniotic cells].
    Magnin C; Debeaux P; Jouvenceaux A
    Rev Fr Transfus Immunohematol; 1978 Jun; 21(3):813-21. PubMed ID: 97766
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of anti-Rh antibodies in amniotic fluid].
    Benoit P; Gagnon M; Doray BH; Bonin A; Bertrand R
    Union Med Can; 1972 Jan; 101(1):58-64. PubMed ID: 4622396
    [No Abstract]   [Full Text] [Related]  

  • 3. The evaluation of maternal anti-D concentrations during pregnancy.
    Filbey D; Berseus O; Sandström B; Wesström G
    Early Hum Dev; 1987 Jan; 15(1):1-9. PubMed ID: 3102209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: Management of maternal isoimmunization.
    Med J Aust; 1974 Oct; 2(15):547-8. PubMed ID: 4214982
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-D (Rh) antibodies in the amniotic fluid].
    Bianchi R; Hille A; Cabrera F; Rojas E
    Rev Chil Obstet Ginecol; 1973; 38(4):172-5. PubMed ID: 4219858
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of the Rh-D antibody titres of amniotic fluids and corresponding maternal sera in Rh-D sensitized pregnancies.
    Usategui-Gomez M; Stearns S
    Nature; 1969 Jan; 221(5175):82-3. PubMed ID: 4973138
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in levels of antibodies in feto-maternal isoimmunization after puncture of the amniotic fluid].
    Streiff F; Peters A; Genetet B; Landes P; Bertrand JM
    Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(5):483-6. PubMed ID: 4992669
    [No Abstract]   [Full Text] [Related]  

  • 8. [Amniotic fluid study for the early diagnosis of hemolytic disease in the intrauterine fetus].
    Karpova SA; Martynshin MIa; Matveeva OF
    Akush Ginekol (Mosk); 1978 Apr; (4):17-20. PubMed ID: 418697
    [No Abstract]   [Full Text] [Related]  

  • 9. Amniotic fluid anti-D and the maternal serum: liquor ratio in rhesus haemolytic disease of the newborn.
    Neil VS; Bowell PJ
    Clin Lab Haematol; 1984; 6(1):39-43. PubMed ID: 6734098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration of anti-D antibodies in Rh(D) alloimmunized pregnant women, as a predictor of anemia and/or hyperbilirubinemia in their newborn infants.
    Gottvall T; Hildén JO
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):733-8. PubMed ID: 9348249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis in Rh incompatibility.
    Lozińska D
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1121-5. PubMed ID: 107914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prenatal diagnosis and therapy of hemolytic disease of the newborn].
    Fischer K; Poschmann A; Hellwege HH; Kitschke HJ; Carstensen M; Sprotte C; Schreer I
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):167-70. PubMed ID: 4010672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of various parameters in the evaluation of the negative iso-immunization Rh factor].
    Bianchi R; Hille A; Saenger S; Cabrera F; Rojas E
    Rev Chil Obstet Ginecol; 1973; 38(5):201-5. PubMed ID: 4215105
    [No Abstract]   [Full Text] [Related]  

  • 14. [The passage of maternal rhesus antibodies into the amniotic fluid and its clinical significance].
    Hoffbauer H
    Z Geburtshilfe Gynakol; 1967 Feb; 166(3):290-301. PubMed ID: 4969772
    [No Abstract]   [Full Text] [Related]  

  • 15. The evaluation of extended analysis of serum, amniotic fluid and cardiotocography in the management of pregnancy complicated by immunization in Rh or Kell antigens.
    Woytoń J; Narczewska B; Gajewska E; Baranowski H; Kwoczyńska K; Dzierzkowa-Borodej W; Partyka T; Bochenek S; Lochocka E
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1131-7. PubMed ID: 107916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prenatal determination of Rho (D)-phenotype of the fetus according to data of the analysis of amniotic fluid cells].
    Ilieva V; Vitanova R; Penev I; Katsulov A
    Akush Ginekol (Mosk); 1974 Jan; (1):60-3. PubMed ID: 4217108
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prediction of fetal blood group from amniotic fluid and use in hemolytic disease of the newborn (author's transl)].
    Qian ML
    Zhonghua Fu Chan Ke Za Zhi; 1982 Jan; 17(1):21-3. PubMed ID: 6807636
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rhesus erythroblastosis, monitoring and treatment].
    Siebers JW; Rasenack R; Hillemanns HG
    Zentralbl Gynakol; 1985; 107(20):1226-42. PubMed ID: 3934880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A management programme for Rh alloimmunization during pregnancy.
    Filbey D; Berseus O; Lindeberg S; Wesström G
    Early Hum Dev; 1987 Jan; 15(1):11-20. PubMed ID: 3102210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of the degree of fetal injury by the Rh antibody titer in the amniotic fluid].
    Vitanova R
    Akush Ginekol (Sofiia); 1985; 24(1):43-7. PubMed ID: 3925801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.